Consensus of oral nutritional supplements for patients with cancer
10.3760/cma.j.cn115822-20240709-00120
- VernacularTitle:肿瘤患者口服营养补充制剂选择专家共识（2024版）
- Author:
Junren KANG
1
;
Kang YU
Author Information
1. 中国医学科学院 北京协和医学院 北京协和医院临床营养科，北京 100730
- Keywords:
Cancer;
Nutritional risk;
Oral nutritional supplements;
Food for special medical purpose;
Enteral nutrition
- From:
Chinese Journal of Clinical Nutrition
2024;32(5):279-288
- CountryChina
- Language:Chinese
-
Abstract:
Patients with cancer are often at nutritional risk and the standardized oral nutritional supplements (ONS) is the preferred treatment for those with gastro-enteral function maintained. ONS could increase the nutrition intake, prevent weight loss, improve the tolerance to anti-cancer treatment, and effectively improve the nutritional status, quality of life and clinical outcomes of cancer patients. The choice of ONS may depend on the type, anatomical location and treatment of cancer. To effectively implement standardized oral nutritional support for patients with cancer, the Nutrition Oncology Branch of Chinese Nutrition Society developed evidence-based, concise and practical recommendations based on the latest clinical nutrition guidelines and research evidence. The purpose is to inform clinical practice and benefit patients with cancer.
